Characterization of Human Engraftment and Hemophagocytic Lymphohistiocytosis in NSG-SGM3 Neonate Mice Engrafted with Purified CD34+ Hematopoietic Stem Cells
Experimental Hematology · 2024
DOI: 10.1016/j.exphem.2023.11.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Hematology, 2024. Verfasst von Liam J O'Brien und 7 weiteren Autor:innen. Beteiligte Einrichtung: Mater Research, The University of Queensland, Woolloongabba, Queensland, Australia. Electronic address: liam.obrien@mater.uq.edu.au. Hauptthemen laut MEDLINE: Lymphohistiocytosis, Hemophagocytic, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Tour de Cure Ltd, Mater Foundation, Australian Government.
Abstract (Originalsprache)
Immunodeficient mice bearing human immune systems, or "humanized" chimeric mice, are widely used in basic research, along with the preclinical stages of drug development. Nonobese diabetic-severe combined immunodeficiency (NOD-SCID) IL2Rγnull (NSG) mice expressing human stem cell factor, granulocyte-macrophage colony stimulating factor, and interleukin-3 (NSG-SGM3) support robust development of human myeloid cells and T cells but have reduced longevity due to the development of fatal hemophagocytic lymphohistiocytosis (HLH). Here, we describe an optimized protocol for development of human immune chimerism in NSG-SGM3 mice. We demonstrate that efficient human CD45+ reconstitution can be achieved and HLH delayed by engraftment of neonatal NSG-SGM3 with low numbers of human umbilical cord-derived CD34+ hematopoietic stem cells in the absence of preconditioning irradiation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Mater Research, The University of Queensland, Woolloongabba, Queensland, Australia. Electronic address: liam.obrien@mater.uq.edu.au.
- Mater Research, The University of Queensland, Woolloongabba, Queensland, Australia.
- Children's Health Research Centre, The University of Queensland, Brisbane, Queensland, Australia; Oncology Service, Children's Health Queensland Hospital and Health Service, Brisbane, Queensland, Australia.
- Mater Research, The University of Queensland, Woolloongabba, Queensland, Australia. Electronic address: kristen.radford@mater.uq.edu.au.
Förderung
- Tour de Cure Ltd
- Mater Foundation
- Australian Government
- Australian Research Council
- Cancer Australia
- Cure Cancer Australia Foundation
Zitieren
APA
O'Brien, L. J., Walpole, C. M., Leal-Rojas, I. M., Shatunova, S., Moore, A., Winkler, I. G., Guillerey, C., & Radford, K. J. (2024). Characterization of Human Engraftment and Hemophagocytic Lymphohistiocytosis in NSG-SGM3 Neonate Mice Engrafted with Purified CD34+ Hematopoietic Stem Cells. Experimental Hematology. https://doi.org/10.1016/j.exphem.2023.11.008
Vancouver
O'Brien LJ, Walpole CM, Leal-Rojas IM, Shatunova S, Moore A, Winkler IG, et al. Characterization of Human Engraftment and Hemophagocytic Lymphohistiocytosis in NSG-SGM3 Neonate Mice Engrafted with Purified CD34+ Hematopoietic Stem Cells. Experimental Hematology. 2024. doi:10.1016/j.exphem.2023.11.008
BibTeX
@article{OBrien2024,
author = {O'Brien, Liam J and Walpole, Carina M and Leal-Rojas, Ingrid M and Shatunova, Svetlana and Moore, Andrew and Winkler, Ingrid G and Guillerey, Camille and Radford, Kristen J},
title = {Characterization of Human Engraftment and Hemophagocytic Lymphohistiocytosis in NSG-SGM3 Neonate Mice Engrafted with Purified CD34+ Hematopoietic Stem Cells},
journal = {Experimental Hematology},
year = {2024},
doi = {10.1016/j.exphem.2023.11.008}
}
EUVIMED